Published in Cancer Weekly, December 21st, 1998
Defective function of dendritic cells (DC) in cancer may represent a mechanism of tumor evasion from control of the immune system, noted Dmitry Gabrilovich, Vanderbilt University School of Medicine, Nashville, Tennessee, and colleagues ("Vascular Endothelial Growth Factor Inhibits the Development of Dendritic Cells and Dramatically Affects the Differentiation of Multiple Hematopoietic Lineages In Vivo," Blood, December 1, 1998;92:4150-4166).
Previously, the research team demonstrated in vitro that vascular endothelial...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.